JP2025102830A5 - - Google Patents
Info
- Publication number
- JP2025102830A5 JP2025102830A5 JP2025045947A JP2025045947A JP2025102830A5 JP 2025102830 A5 JP2025102830 A5 JP 2025102830A5 JP 2025045947 A JP2025045947 A JP 2025045947A JP 2025045947 A JP2025045947 A JP 2025045947A JP 2025102830 A5 JP2025102830 A5 JP 2025102830A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361790469P | 2013-03-15 | 2013-03-15 | |
| US61/790,469 | 2013-03-15 | ||
| JP2019113626A JP7046871B2 (ja) | 2013-03-15 | 2019-06-19 | ペプチド組成物 |
| JP2022048719A JP7654587B2 (ja) | 2013-03-15 | 2022-03-24 | ペプチド組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022048719A Division JP7654587B2 (ja) | 2013-03-15 | 2022-03-24 | ペプチド組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025102830A JP2025102830A (ja) | 2025-07-08 |
| JP2025102830A5 true JP2025102830A5 (enExample) | 2025-12-11 |
Family
ID=50588892
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502840A Active JP6622690B2 (ja) | 2013-03-15 | 2014-03-14 | ペプチド組成物 |
| JP2019113626A Active JP7046871B2 (ja) | 2013-03-15 | 2019-06-19 | ペプチド組成物 |
| JP2022048719A Active JP7654587B2 (ja) | 2013-03-15 | 2022-03-24 | ペプチド組成物 |
| JP2025045947A Pending JP2025102830A (ja) | 2013-03-15 | 2025-03-19 | ペプチド組成物 |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016502840A Active JP6622690B2 (ja) | 2013-03-15 | 2014-03-14 | ペプチド組成物 |
| JP2019113626A Active JP7046871B2 (ja) | 2013-03-15 | 2019-06-19 | ペプチド組成物 |
| JP2022048719A Active JP7654587B2 (ja) | 2013-03-15 | 2022-03-24 | ペプチド組成物 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US10196425B2 (enExample) |
| EP (2) | EP2970388B1 (enExample) |
| JP (4) | JP6622690B2 (enExample) |
| CN (3) | CN118240012A (enExample) |
| AU (5) | AU2014227712B2 (enExample) |
| CA (1) | CA2906694A1 (enExample) |
| ES (1) | ES2693761T3 (enExample) |
| RU (2) | RU2725150C2 (enExample) |
| TR (1) | TR201815173T4 (enExample) |
| WO (1) | WO2014144260A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS62701B1 (sr) | 2011-12-29 | 2022-01-31 | Rhythm Pharmaceuticals Inc | Postupak lečenja poremećaja u vezi sa melanokortin-4 receptorom u heterozigotnim nosiocima |
| CA2906694A1 (en) | 2013-03-15 | 2014-09-18 | Rhythm Metabolic, Inc. | Peptide compositions |
| EP3778623A1 (en) * | 2013-03-15 | 2021-02-17 | Rhythm Pharmaceuticals, Inc. | Pharmaceutical compositions |
| WO2016168388A2 (en) | 2015-04-14 | 2016-10-20 | Palatin Technologies, Inc. | Therapies for obesity, diabetes and related indications |
| EP3356386B1 (en) * | 2015-09-30 | 2024-02-14 | Rhythm Pharmaceuticals, Inc. | Method of treating melanocortin-4 receptor pathway-associated disorders |
| US11591367B2 (en) * | 2016-10-04 | 2023-02-28 | Dsm Ip Assets B.V. | Melanocortin-1-receptor agonists |
| EP3596107A1 (en) * | 2017-03-15 | 2020-01-22 | Novo Nordisk A/S | Bicyclic compounds capable of binding to melanocortin 4 receptor |
| AU2019249255A1 (en) | 2018-04-06 | 2020-11-05 | Alastair GARFIELD | Compositions for treating kidney disease |
| WO2020053414A1 (en) * | 2018-09-14 | 2020-03-19 | Novo Nordisk A/S | Bicyclic compounds capable of acting as melanocortin 4 receptor agonists |
| MX2023003360A (es) * | 2020-09-24 | 2023-06-23 | Rhythm Pharmaceuticals Inc | Metodos de tratamiento de trastornos asociados a la via del receptor de melanocortina-4. |
| CN113209270B (zh) * | 2021-05-17 | 2022-02-22 | 宁波大学 | 丙谷二肽在制备防治急性肝衰竭药物中的应用 |
| CN113332416B (zh) * | 2021-05-17 | 2022-02-22 | 宁波大学 | 丙谷二肽在制备治疗非酒精性脂肪肝药物中的应用 |
| CN116789802A (zh) * | 2023-06-25 | 2023-09-22 | 湖北省农业科学院畜牧兽医研究所 | 一种山羊mc4r增强型突变体及其应用 |
| CN120192363A (zh) * | 2023-12-22 | 2025-06-24 | 上海多米瑞生物技术有限公司 | 多肽化合物、其药物组合物及其用途 |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0292291B1 (en) * | 1987-05-22 | 1994-08-10 | University Patents, Inc. | Linear and cyclic analogs of alpha-msh fragments with extraordinary potency |
| US5731408A (en) | 1995-04-10 | 1998-03-24 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Peptides having potent antagonist and agonist bioactivities at melanocortin receptors |
| GB9827500D0 (en) * | 1998-12-14 | 1999-02-10 | Wapharm Ab | Compounds for control of eating, growth and body weight |
| US7176279B2 (en) | 2000-06-28 | 2007-02-13 | Palatin Technologies, Inc. | Cyclic peptide compositions and methods for treatment of sexual dysfunction |
| RU2239642C1 (ru) * | 2000-08-30 | 2004-11-10 | Ф.Хоффманн-Ля Рош Аг | Селективные циклопептиды |
| US7345144B2 (en) * | 2001-07-11 | 2008-03-18 | Palatin Technologies, Inc. | Cyclic peptides for treatment of cachexia |
| US7342089B2 (en) * | 2001-07-11 | 2008-03-11 | Palatin Technologies, Inc. | Cyclic peptides for treatment for cachexia |
| JP2004534851A (ja) * | 2001-07-11 | 2004-11-18 | パラチン テクノロジーズ インク． | メラノコルチン受容体に特異的な線状および環状ペプチド |
| US7034004B2 (en) * | 2002-05-07 | 2006-04-25 | University Of Florida | Peptides and methods for the control of obesity |
| FR2851563B1 (fr) | 2003-02-26 | 2005-04-22 | Sod Conseils Rech Applic | Nouveaux derives de benzimidazole et d'imidazo-pyridine et leur utilisation en tant que medicament |
| FR2852957B1 (fr) | 2003-03-31 | 2005-06-10 | Sod Conseils Rech Applic | Nouveaux derives d'imidazo-pyridine et leur utilisation en tant que medicament |
| US20070105759A1 (en) * | 2003-06-19 | 2007-05-10 | Eli Lilly And Company | Melanocortin receptor 4 (mc4) agonists and their uses |
| US20060293223A1 (en) * | 2003-06-19 | 2006-12-28 | Eli Lilly And Company Patent Division | Uses of melanocortin-3 receptor (mc3r) agonist peptides |
| FR2862971B1 (fr) | 2003-11-28 | 2006-03-24 | Sod Conseils Rech Applic | Nouveaux derives de benzimidazole et d'imidazo-pyridine et leur utilisation en tant que medicament |
| US8343031B2 (en) * | 2004-03-23 | 2013-01-01 | Michael Gertner | Obesity treatment systems |
| FR2872165B1 (fr) | 2004-06-24 | 2006-09-22 | Sod Conseils Rech Applic | Nouveaux derives de pyrimido-benzimidazole |
| EP3925614A3 (en) * | 2005-07-08 | 2022-03-23 | Ipsen Pharma | Melanocortin receptor ligands |
| RU2401841C2 (ru) | 2005-07-08 | 2010-10-20 | Ипсен Фарма С.А.С. | Лиганды рецепторов меланокортинов |
| US8563000B2 (en) | 2007-05-25 | 2013-10-22 | Ipsen Pharma S.A.S. | Melanocortin receptor ligands modified with hydantoin |
| WO2008156677A2 (en) | 2007-06-15 | 2008-12-24 | Ipsen Pharma S.A.S. | Cyclic peptide melanocortin receptor ligands |
| DK2214693T3 (en) | 2007-11-05 | 2015-11-30 | Ipsen Pharma Sas | Use of melanocortins in the treatment of insulin sensitivity |
| AR072072A1 (es) * | 2008-06-09 | 2010-08-04 | Palatin Technologies Inc | Peptidos especificos del receptor de melanocortina para el tratamiento de la obesidad / 669 |
| CN105037502A (zh) * | 2009-06-08 | 2015-11-11 | 帕拉丁科技公司 | 黑皮质素受体特异性肽 |
| UY32690A (es) * | 2009-06-08 | 2011-01-31 | Astrazeneca Ab | Péptidos específicos para receptores de melanocortina |
| MX2012001513A (es) * | 2009-08-05 | 2012-05-22 | Ipsen Pharma Sas | Uso de melanocortinas para tratar la dislipidemia. |
| ES2654147T3 (es) | 2009-11-16 | 2018-02-12 | Ipsen Pharma S.A.S. | Composiciones farmacéuticas de ligandos del receptor de melanocortina |
| WO2011060355A1 (en) * | 2009-11-16 | 2011-05-19 | Ipsen Pharma S.A.S | Process for the synthesis of ac-arg-cyclo(cys-d-ala-his-d-phe-arg-trp-cys)-nh2 |
| US9415012B2 (en) | 2011-06-14 | 2016-08-16 | Ipsen Pharma S.A.S. | Sustained-release composition containing peptides as active ingredient |
| EP2705835A1 (en) | 2012-06-08 | 2014-03-12 | Ipsen Pharma S.A.S. | Aqueous gelling compositions of soluble active pharmaceutical peptides providing modified release |
| CA2906694A1 (en) | 2013-03-15 | 2014-09-18 | Rhythm Metabolic, Inc. | Peptide compositions |
| EP3778623A1 (en) * | 2013-03-15 | 2021-02-17 | Rhythm Pharmaceuticals, Inc. | Pharmaceutical compositions |
-
2014
- 2014-03-14 CA CA2906694A patent/CA2906694A1/en active Pending
- 2014-03-14 RU RU2015145593A patent/RU2725150C2/ru active
- 2014-03-14 TR TR2018/15173T patent/TR201815173T4/tr unknown
- 2014-03-14 WO PCT/US2014/028590 patent/WO2014144260A1/en not_active Ceased
- 2014-03-14 JP JP2016502840A patent/JP6622690B2/ja active Active
- 2014-03-14 RU RU2020120797A patent/RU2020120797A/ru unknown
- 2014-03-14 EP EP14719988.9A patent/EP2970388B1/en active Active
- 2014-03-14 CN CN202410043141.5A patent/CN118240012A/zh active Pending
- 2014-03-14 CN CN202410043113.3A patent/CN118271400A/zh active Pending
- 2014-03-14 CN CN201480026843.7A patent/CN105492456B/zh active Active
- 2014-03-14 AU AU2014227712A patent/AU2014227712B2/en active Active
- 2014-03-14 ES ES14719988.9T patent/ES2693761T3/es active Active
- 2014-03-14 US US14/775,916 patent/US10196425B2/en active Active
- 2014-03-14 EP EP18183527.3A patent/EP3450449A3/en active Pending
-
2018
- 2018-10-30 AU AU2018256493A patent/AU2018256493A1/en not_active Abandoned
- 2018-12-11 US US16/216,116 patent/US10858399B2/en active Active
-
2019
- 2019-06-19 JP JP2019113626A patent/JP7046871B2/ja active Active
-
2020
- 2020-05-22 AU AU2020203353A patent/AU2020203353A1/en not_active Abandoned
- 2020-10-26 US US17/080,293 patent/US12077612B2/en active Active
-
2021
- 2021-11-18 AU AU2021269411A patent/AU2021269411A1/en not_active Abandoned
-
2022
- 2022-03-24 JP JP2022048719A patent/JP7654587B2/ja active Active
-
2024
- 2024-01-29 AU AU2024200528A patent/AU2024200528A1/en active Pending
- 2024-07-24 US US18/782,986 patent/US20250188124A1/en active Pending
-
2025
- 2025-03-19 JP JP2025045947A patent/JP2025102830A/ja active Pending